Tag: Allergan

January 7, 2019 Off

Allergan with positive topline results for Bimatoprost implant for reduction of IOP

By Dino Mustafić

Allergan announced positive 3-month topline results from the second pivotal clinical trial of Bimatoprost SR, a first-in-class sustained-release, biodegradable implant for the reduction of IOP in patients with open-angle glaucoma or ocular hypertension, while the global pharmaceutical leader noted the positive results from the first Phase 3 trial were reported in June 2018.